EGFR and lung cancer: The authors also found that the (Z)-TMS inhibited the phosphorylation and activation of EGFR in gefitinib-resistance lung cancer cells, induced caspase-independent apoptosis, and autophagy, and causing endoplasmic reticulum (ER) stress and AMPK activation [98].